CHENGDU, China, June 3, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co. , Ltd. (“Kelun-Biotech” or the “Company”, 6990. HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, the first-in-human study results of the. ..



